Development of a central nervous system axonal myelination assay for high throughput screening

BACKGROUND: Regeneration of new myelin is impaired in persistent multiple sclerosis (MS) lesions, leaving neurons unable to function properly and subject to further degeneration. Current MS therapies attempt to ameliorate autoimmune-mediated demyelination, but none directly promote the regeneration...

Descripción completa

Detalles Bibliográficos
Autores principales: Lariosa-Willingham, Karen D., Rosler, Elen S., Tung, Jay S., Dugas, Jason C., Collins, Tassie L., Leonoudakis, Dmitri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Methodology Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840960/
https://www.ncbi.nlm.nih.gov/pubmed/27103572
http://dx.doi.org/10.1186/s12868-016-0250-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840960/
https://www.ncbi.nlm.nih.gov/pubmed/27103572
http://dx.doi.org/10.1186/s12868-016-0250-2

Ejemplares similares